Our People

For the past decade, Tom has partnered with Pharma and Biotech companies to develop global programs, providing patients with access to treatments that would otherwise be unavailable to them. During this time, he has been involved in setting up and running over 300 regional and global EAPs. He has over 20 years’ experience of leading a wide range of global pre-launch and launch activities for treatments addressing areas of high unmet medical need.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed scelerisque ante eleifend nisi lacinia, eget vehicula sapien fringilla. Fusce sit amet vulputate augue, sit amet consectetur risus. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Vivamus bibendum faucibus semper. Morbi luctus et ante ac aliquam. Donec eget elementum sapien, tincidunt vestibulum lacus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras ullamcorper sed massa sed.

Roseanne leads our hardworking, dedicated Legal Team at Bionical Emas. She works collaboratively across the business to ensure that all our activities' legal and regulatory platforms are robust and safe. This includes Bionical Emas’ employees and clients, as well as our patients. She has been an integral part of our ongoing expansion as an innovative business.

John is responsible for providing medical leadership and oversight for Bionical Emas’ clinical development studies, Early Access Programs and corporate medical matters. John is a board certified/specialist accredited physician trained in London and Oxford university hospitals, with wide clinical experience in the care of patients, including those with cancer, and respiratory, infectious and rare diseases. He has over 25 years of global drug development experience in senior medical and R&D roles (CMO, SVP, Exec VP), in and advising la